结直肠癌分子生物学特征及临床特征与预后的关系
作者:
通讯作者:
作者单位:

作者简介:

李军

基金项目:


The relationship between the molecular biology and the clinical characters and prognosis of colorectal cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:研究结直肠癌分子生物学特征及临床病理特征与和预后关系
    方法:对317例结直肠癌患者的分子生物学特征及临床特征和预后进行单因素分析,取有统计学差异的因素进入Cox模型行多因素分析并作风险评估
    结果:Kaplan-Meier法显示p53,C-erb-2,nm23,CEA,分化程度,Dukes分期这6种因素在分组间有统计学差异(均P<0.05)。而Cox模型分析显示Dukes分期,C-erb-2,nm23, p53 这四种因素,是预测结直肠癌预后的独立因素(P<0.05,r均<1)。Dukes分期升高和nm23表达阴性,p53和 C-erb-2表达阳性者预后差;反之则预后较好。
    结论:结直肠癌C-erb-2,nm23, p53癌基因与临床Dukes分期相结合能更好地预测其预后。

    Abstract:

    Abstract:Objective:To study the relationship between the molecular biology and the clinicopathologic characters with prognosis of colorectal cancer.
    Methods :The molecular biology traits and clinical characters and prognosis of 317 colorectal cancer patients were compared by mono-factorial analysis; some of them regarded as statistical difference by mono-factorial analysis were analyzed with Cox model.
    Results:There was statistical difference for the p53,C-erb-2,nm23,CEA,cell differentiation and Dukes stages with Kaplan-meier′s method (P>0.05). p53,C-erb-2,nm23 and Dukes stages with Cox model (P>0.05). The prognosis was worse with increase in Dukes stage, negative expression of gene nm23, and positive expression of gene p53 and C-erb-2. Reverse expressions had better prognosis.
    Conclusions:It can be likely to get a more reliable prognosis predication if a combine examination together with p53, C-erb-2, nm23 and their clinical pathology such as Dukes stages, was done in colorectal cancer patients.

    参考文献
    相似文献
    引证文献
引用本文

李军, 陈建中, 孙保军, 姜卫东.结直肠癌分子生物学特征及临床特征与预后的关系[J].中国普通外科杂志,2008,17(4):11-339.
DOI:10.7659/j. issn.1005-6947.2008.04.011

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2008-04-25